KMT2A and leukemia: Although the pathomechanism of t(4;11)-mediated leukemia is still discussed controversially, expression of the AF4•MLL fusion enhanced the hematopoietic repopulating potential of CD34+ cells, and led to the development of predominantly proB ALL in a mouse model [2], [3].